Battery innovation and the next wave of orthopaedic implants

Ilika Plc

Orthopaedic procedures today restore quality of life for millions each year, but failure rates remain a pressing issue. Infection, loosening, or mechanical collapse often reveal themselves only when pain returns, by which point revision surgery is the only option. The next generation of implants is being built to change that timeline entirely. By embedding sensors capable of measuring pressure, movement, and temperature, these devices can provide surgeons with a real-time window into the health of the joint.

Yet the ability to collect and send this information rests on a problem many overlook: powering the device without compromising its structural integrity. Conventional batteries are too bulky or unreliable to integrate safely into implants. This is where miniature solid state batteries enter the conversation. Designed at millimetre scale, they can be embedded within a prosthetic without weakening it, while still delivering the performance needed to drive sensors and communications.

Ilika’s Stereax M300, for instance, has been designed to address exactly these constraints. With a rectangular footprint just a few millimetres across, it offers the compactness necessary for true miniaturisation. Despite its size, it is capable of producing the pulse currents required for both sensing and wireless transmission. Equally important is the ability to recharge quickly and wirelessly, which not only ensures the longevity of the implant but also supports patient compliance by making at-home charging feasible and convenient.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search